Recruiting

Taurine

Sponsor:

York University

Code:

NCT07312409

Conditions

Long COVID Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Taurine supplementation

Study Details

Brief summary:

Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-weeks of taurine supplementation (self-administered), on vascular function and the cardio/cerebrovascular responses to upright posture. We will measure resting vascular function with an EndoPAT device, resting heart rate variability, and the blood pressure, heart rate, and brain blood flow responses to 5 minutes of head-up tilt before and after weeks of taurine supplementation in LC. We hypothesize that the 12 weeks of supplementation will improve both resting vascular function and the responses to upright tilt. In turn, we hypothesize that symptoms will also improve (as measured by questionnaires).

Conditions

Long COVID Syndrome

Study ID

NCT07312409

Start date

Jun 1, 2026

Status verified date

Jun, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Jun 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participants will have had symptoms of Long COVID post-infection for at least 3 months

Exclusion Criteria:

  • Inability to undergo tilt table testing for 5 minutes
  • Inability to transport selves to York University from their homes
  • Inability to speak English, or provide a translator
  • Blood clotting disorders

Study Design

Enrollment

30 participants

Anticipated

Interventions and Outcome Measures

Arms

Taurine supplementation

Long COVID patients will self-administer 12-wks of taurine supplementation

Time control

Long COVID patients who are not taking taurine supplementation

Interventions

Taurine supplementation

Participants will self-administer 12-wks taurine supplementation

Primary outcome measure

  • Orthostatic responses [ Time Frame: Baseline and 12-weeks ]
  • Vascular function [ Time Frame: Baseline and 12-weeks ]

Central Contacts and Locations

Central contacts

Heather Edgell, PhD

14167362100edgell@yorku.ca

Locations

York University

Recruiting

Toronto, Ontario, Canada, M3J1P3

Contacts

More Information

Sponsor

York University

Last update posted

Jun 5, 2026

Last verified

Jun, 2026

Keywords

  • Taurine
  • Vascular
  • Long COVID
  • Orthostatic
  • Cerebrovascular
  • Heart rate variability

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by York University on 2026-06-05.